# AYURVEDA PRODUCT MARKET-READINESS & COMPLIANCE ENGINE
## Implementation & Verification Audit Report

**Date**: 2026-09-04  
**System**: IP-SAKTI Sahayak  
**Capability**: Ayurveda Product Market-Readiness & Evidence Verification Assistant  
**Dataset Invariant Hash**: `827f8a209ff7cbc86c00931fbb97d6eeaa861cdf360fa8770dafcf0fab05700d` (PASS)

---

## 1. Objective
Extend the existing IP-SAKTI Sahayak platform with a specialized pre-screening and document verification engine: **"AYURVEDA PRODUCT MARKET-READINESS & COMPLIANCE ASSISTANT"**.
The assistant enables Ayurvedic medicine manufacturers, herbal formulation developers, and regulatory consultants to evaluate:
1. Preliminary product categorization (`AYURVEDIC_MEDICINE`, `AYURVEDIC_PROPRIETARY_MEDICINE`, `CLASSICAL_AYURVEDIC_FORMULATION`, `FOOD_OR_NUTRACEUTICAL`, `COSMETIC_OR_PERSONAL_CARE`, `UNCLEAR`, `REQUIRES_CLARIFICATION`).
2. Identification of governing regulatory pathways (Drugs & Cosmetics Act 1940, Rule 153/158-B, Schedule T GMP, FSSAI Ayurveda Aahara 2022, Cosmetics Rules 2020).
3. 13-point statutory document gap analysis (`AVAILABLE`, `MISSING`, `UNVERIFIED`, `NOT_APPLICABLE`).
4. Claims risk scrutiny against the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and FSSAI advertising codes.
5. Ingredient pharmacopoeial verification (Ayurvedic Pharmacopoeia of India - API, Ayurvedic Formulary of India - AFI).
6. Traditional Knowledge (TK) identification, Section 3(p) patent exclusions, and TKDL boundaries.
7. Biological Diversity Act, 2002 / Access and Benefit Sharing (ABS) mandates (Section 6 NBA prior approval).
8. Potentially applicable Intellectual Property routes (Trademark, Patent, Industrial Design, Copyright, Trade Secret, GI).
9. Generation of a structured 17-section pre-market audit report.

---

## 2. Existing Architecture Reused
In strict adherence to the non-negotiable invariant **DO NOT BUILD A SECOND RAG**:
- Reused existing frozen RAG pipeline (`RagClient` communicating with `POST /api/v1/ask` on port 8000).
- Reused canonical dataset and embedding index without regenerating chunks, metadata, or indices.
- Reused `FormulationRuleEngine`, `RegulatoryRouteService`, and `FormulationClarificationService`.
- Reused existing multilingual translation pipeline (`TranslationService`) supporting 6 Indian languages (EN, HI, TA, TE, KN, ML).
- Reused existing Spring Boot security filter chain, dev-mode authentication, and CORS configurations.

```
User Formulation Input & Documents
               ↓
AyurvedaProductReadinessService (Spring Boot)
               ↓
Multi-Domain RAG Retrieval via existing RagClient
[ AYURVEDA / DRUGS ACT ] + [ PATENT / SEC 3(p) ] + [ ABS / NBA SEC 6 ]
               ↓
Evidence-Grounded Extraction & Citation Validation
               ↓
13-Point Document Gap Analysis + Claims Risk Classification
               ↓
Discrete Readiness Scoring (No Arbitrary Points)
               ↓
17-Section Regulatory Audit Report & JSON API
               ↓
Frontend 5-Step Wizard (React + TypeScript)
```

---

## 3. Product Analysis Flow
The engine executes a rigorous multi-stage pipeline:
1. **Input Normalization & Canonical Translation**: Preserves user input across requested languages, routing canonical English text to RAG while translating final recommendations back to the target language.
2. **Multi-Domain Evidence Retrieval**: Queries authoritative corpus across:
   - Drugs and Cosmetics Act & Rules (Chapter IV-A, Rules 153-158B).
   - Ayurvedic Pharmacopoeia of India (API) & Ayurvedic Formulary of India (AFI).
   - Patents Act, 1970 (Section 3(p) traditional knowledge exclusion & Section 3(e) mere admixture).
   - Biological Diversity Act, 2002 (Section 6 NBA approval for IP on Indian biological resources).
   - FSSAI Food Safety and Standards (Ayurveda Aahara) Regulations, 2022.
3. **Statutory Document Gap Analysis**: Cross-examines provided documents against 13 mandatory licensing areas.
4. **Claims Scrutiny**: Inspects claims against statutory prohibitions (e.g. Schedule J diseases, cancer, diabetes cures).
5. **Ingredient Verification**: Cross-references botanical binomials, common names, parts used, and pharmacopoeial monographs.
6. **Discrete Readiness Scoring**: Evaluates 7 distinct readiness vectors into standard status tiers.
7. **17-Section Audit Report Generation**: Formats findings with conservative, advisory disclaimers.

---

## 4. Regulatory Analysis
Preliminary classifications map strictly to statutory categories:
- **`CLASSICAL_AYURVEDIC_FORMULATION`**: Governed by Chapter IV-A of Drugs & Cosmetics Act, 1940. Requires textual citation in treatises listed in the First Schedule. SLA: State Licensing Authority (AYUSH).
- **`AYURVEDIC_PROPRIETARY_MEDICINE`**: Governed by Section 3(h) of Drugs & Cosmetics Act. Requires safety/efficacy data under Rule 158-B, standardized ingredients, and Schedule T GMP compliance.
- **`FOOD_OR_NUTRACEUTICAL`**: Governed by FSSAI Ayurveda Aahara Regulations, 2022. Excludes therapeutic/disease claims.
- **`COSMETIC_OR_PERSONAL_CARE`**: Governed by Cosmetics Rules, 2020. Exclusively topical for cleansing, beautifying, or altering appearance without therapeutic intervention.
- **`UNCLEAR` / `REQUIRES_CLARIFICATION`**: Triggered when inputs contain contradictory signals (e.g., therapeutic disease cure claims for an herbal tea).

---

## 5. Document Verification
The system evaluates 13 distinct document categories:
1. Product Formulation Specification (Master formula, ratios, excipients)
2. Classical Text Reference (Treatise chapter/verse citation)
3. Ingredient Sourcing & Botanical Records (Geographical origin, vendor traceability)
4. Manufacturing Flowchart & Method of Preparation (Schedule T GMP)
5. Quality Testing & NABL Laboratory Certificate of Analysis (Assays, heavy metals, microbial counts)
6. Stability Study Data (Shelf-life & degradation under Zone IVb conditions)
7. Product Label Mockup (Rule 161 compliance, warnings, batch details)
8. Trademark Clearance / Registration Record (Class 5, Class 3, or Class 30)
9. Traditional Knowledge Evidence / Prior Art
10. Biological Resource Traceability Records
11. National Biodiversity Authority (NBA) Section 6 Prior Approval / SBB Intimation
12. Existing Regulatory License Records
13. Patent / Prior Art Documentation

Each document is tagged: `DOCUMENT_PROVIDED`, `DOCUMENT_VERIFIED`, `DOCUMENT_MISSING`, `DOCUMENT_UNVERIFIED`, or `DOCUMENT_NOT_APPLICABLE`. User documents are treated as candidate evidence, never as self-authenticating official licenses.

---

## 6. Claims Analysis
Stated claims are parsed and classified into statutory tiers:
- `GENERAL_WELLNESS`: Non-therapeutic health promotion ("supports natural vitality", "promotes digestion").
- `TRADITIONAL_USE`: Grounded classical indications with textual references ("traditional joint support as per Sharangadhara Samhita").
- `THERAPEUTIC_CLAIM`: Specific physiological action requiring AYUSH Rule 158-B clinical/published trial evidence.
- `DISEASE_CLAIM`: Explicit disease prevention/treatment/cure claims ("cures diabetes", "treats cancer") flagged as **HIGH RISK** under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
- `NUTRITIONAL_CLAIM`: Dietary supplement claims under FSSAI.
- `UNSUPPORTED_FROM_AVAILABLE_EVIDENCE`: Claims lacking substantiated pharmacopoeial basis.

---

## 7. Traditional Knowledge (TK) Analysis
- Distinguishes general traditional knowledge from formal **TKDL (Traditional Knowledge Digital Library)** citations.
- Explicitly cites **Section 3(p) of the Patents Act, 1970**, which excludes an invention which in effect is traditional knowledge or an aggregation or duplication of known properties of traditionally known components.
- Highlights that classical formulations cannot be patented per se; patentability is restricted to non-obvious technological extractions, novel delivery matrices, or synergistic bio-enhancements overcoming Section 3(e) mere admixture hurdles.

---

## 8. Biodiversity / Access and Benefit Sharing (ABS) Analysis
- Flags biological resource usage when Indian botanical materials are identified.
- Evaluates compliance with **Section 6 of the Biological Diversity Act, 2002**, requiring prior approval from the National Biodiversity Authority (NBA) before applying for any intellectual property right in or outside India based on biological resources obtained from India or associated traditional knowledge.
- Notes provisions of the Biological Diversity (Amendment) Act, 2023, which exempt cultivated medicinal plants and registered AYUSH practitioners from certain access procedures while maintaining Section 6 IP application requirements.

---

## 9. IP Protection Analysis
Evaluates all relevant intellectual property avenues:
- **Trademark (High)**: Brand name, logo, packaging trade dress protectable under the Trade Marks Act, 1999 (Classes 5, 3, 30).
- **Patent (Conditional)**: Evaluated conservatively; highlighted as excluded under Section 3(p) for classical formulas, or eligible for consideration only if novel delivery vectors/carriers overcome Section 3(e) and Section 3(p).
- **Industrial Design (Medium)**: Novel bottle shapes, packaging blister contours protectable under Designs Act, 2000.
- **Copyright (High)**: Original packaging artwork, label graphics, product literature protected under Copyright Act, 1957.
- **Trade Secret (Medium)**: Specialized proprietary processing conditions (temperatures, purification sequences) protected via NDAs and common law.
- **Geographical Indication (Origin-Linked)**: Relevant when raw materials originate from certified GI zones (e.g., Malabar Pepper, Kashmir Saffron, Darjeeling).

---

## 10. Evidence Hierarchy & Grounding
Retrieval strictly adheres to the mandated statutory hierarchy:
1. Indian Government Statutes & Acts (Drugs & Cosmetics Act 1940, Patents Act 1970, Biological Diversity Act 2002, Trade Marks Act 1999, FSS Act 2006)
2. Official Statutory Rules & Guidelines (Drugs & Cosmetics Rules 1945, Cosmetics Rules 2020, FSSAI Ayurveda Aahara Regulations 2022)
3. Ministry of AYUSH Notifications & Pharmacopoeial Monographs (API, AFI)
4. State Licensing Authority (SLA) & CDSCO Guidelines
5. Office of the Controller General of Patents, Designs and Trade Marks (IP India)
6. National Biodiversity Authority (NBA) Official Orders
7. WIPO / WTO treaties and international conventions in the frozen corpus

---

## 11. Safety, Abstention & Non-Definitive Phrasing
- Prohibited Terminology: The system NEVER outputs "Approved", "Certified", "Legally compliant", "Safe for sale", "Patent guaranteed", or "Ready for market".
- Permitted Conservative Terminology: Uses "potentially applicable", "appears consistent with", "requires verification", "evidence indicates", "available documents support", "additional documentation may be required".
- Abstention: If RAG evidence is absent or contradictory, the system abstains with `INSUFFICIENT_EVIDENCE` or `REQUIRES_CLARIFICATION` rather than hallucinating regulatory facts.

---

## 12. API Changes
- **`POST /api/v1/formulations/analyze`**: Extended formulation readiness endpoint returning full `ProductReadinessResponse`:
  - `product`: Product details, dosage form, manufacturer, target market.
  - `classification`: Assessed category, internal code, confidence, status, rationale.
  - `regulatory`: Pathway, governing framework, licensing authority, standards.
  - `documents`: Document evaluation, verification notice, total provided.
  - `ingredients`: Verification list with botanical names and pharmacopoeial notes.
  - `claims`: Statutory claim categorization, risk flags, regulatory references.
  - `traditionalKnowledge`: TK status, Section 3(p) patent implications, classical text references.
  - `biodiversityAbs`: NBA Section 6 obligations, 2023 amendment guidance.
  - `ip`: Full IP route assessment with relevance scores and statutory citations.
  - `gaps`: 13-point document checklist with status, importance, and reasons.
  - `nextSteps`: Prioritized pre-market regulatory action steps.
  - `citations`: Deduplicated, validated RAG evidence citations.
  - `scores`: 7 discrete readiness ratings.
  - `report`: Complete 17-section Markdown report.
- **`POST /api/v1/formulations/classify`**: 100% backwards-compatible endpoint preserved.

---

## 13. Frontend Changes
Upgraded `Frontend/src/pages/FormulationPage.tsx` into a 5-step wizard:
- **Step 1: Product Details**: Full product metadata, manufacturer, target market, dosage form, ingredients, ratios, source of materials, and 3 preloaded samples (🌿 Classical Triphala Guggulu, 🍵 AyurVital Herbal Tea, 🔬 CurcuNano Nanogel).
- **Step 2: Documents & Evidence**: Interactive statutory document checklist with toggle selection, plus custom document attachment modal.
- **Step 3: Claims & Positioning**: Line-by-line claim entry, classical basis toggle, commercial intent toggle, language selector.
- **Step 4: Pre-Flight Review**: Summary review card displaying all inputs and attached documents prior to execution.
- **Step 5: Assessment Report**:
  - Calm status banner (`READY FOR FURTHER REGULATORY REVIEW`, `REQUIRES DOCUMENT COMPLETION`, `REQUIRES REGULATORY REVIEW`).
  - 7 discrete score cards.
  - 6 interactive tabs: Pathway & Core, Document Gaps (13-point table), Claims & Ingredients, IP & TK & ABS, Actionable Next Steps, and Full 17-Section Markdown Audit Report with Copy & Print buttons.

---

## 14. Test Results
### Backend Tests (`ip-sakti-backend`)
- `AyurvedaProductReadinessServiceTest`: 7/7 PASSED (Classical formulation, proprietary formulation, Ayurveda Aahara food, cosmetic cream, prohibited disease claim, missing documents, negative safety phrasing guarantees).
- `FormulationControllerTest`: 5/5 PASSED.
- `FormulationControllerSecurityTest`: 2/2 PASSED.
- **Full Backend Suite**: **176/176 PASSED (0 failures, 0 errors)**.

### Frontend Tests (`Frontend`)
- `FormulationPage.test.tsx`: 2/2 PASSED (Wizard navigation, sample loading, document checklist, assessment rendering).
- **Full Frontend Vitest Suite**: **29/29 PASSED in 10 test files (0 failures)**.
- **Frontend Build (`tsc -b && vite build`)**: Completed in 1.46s with zero errors.

### Python RAG Tests (`ip-sakti-rag`)
- **Full Pytest Suite**: **77 passed, 30 skipped, 0 failures**.

---

## 15. Live Browser Results
Frontend assets built directly into `ip-sakti-backend/src/main/resources/static/`. Single unified build verified:
- UI loads with clean Material Design styling.
- Preloading all 3 sample formulations works instantaneously.
- Step-by-step navigation operates smoothly with field validation.
- Responsive layout handles mobile and desktop viewports without overflow.
- 17-section report markdown copies cleanly to clipboard and prints to PDF.

---

## 16. Dataset Invariant Hash Verification
```
Dataset File: ip-sakti-rag/dataset/canonical/chunks.jsonl
Expected SHA-256: 827f8a209ff7cbc86c00931fbb97d6eeaa861cdf360fa8770dafcf0fab05700d
Actual SHA-256:   827f8a209ff7cbc86c00931fbb97d6eeaa861cdf360fa8770dafcf0fab05700d
Status:           100% MATCH — DATASET UNTOUCHED (PASS)
```

---

## 17. Security Audit
- Endpoint security preserved: `@WebMvcTest` with Spring Security test pass.
- API Key validation verified under `app.security.mode=prod`.
- No user-uploaded documents stored permanently to arbitrary disk paths without sanitization.
- No arbitrary remote script execution or secondary network RAG calls.

---

## 18. Limitations
- Pre-screening engine: Cannot verify physical chemical adulteration, pesticide contamination, or microbial counts without certified NABL laboratory testing.
- Advisory only: Does not replace statutory inspection or formal licensing by State AYUSH authorities.
- Static corpus boundary: Evaluates legal status strictly against the frozen authoritative legal corpus.

---

## 19. Known Risks & Mitigations
| Risk | Mitigation |
| :--- | :--- |
| User misinterpreting output as official market approval | Explicit disclaimers on every card, banner, and in Section 1 of the report; strictly prohibited approval keywords |
| Fraudulent or exaggerated disease claims | Rigorous regex and RAG matching against Schedule J of Drugs and Magic Remedies Act |
| Patent misrepresentation for classical knowledge | Mandatory Section 3(p) citation and warning on every classical formulation |
| Biological resource access violation | Mandatory Section 6 NBA notification on all Indian biological ingredient inputs |

---

## 20. Final Verdict

```
============================================================
AYURVEDA PRODUCT READINESS FINAL VERDICT
============================================================
CLASSIFICATION:               CLASSICAL_AYURVEDIC_FORMULATION / AYURVEDIC_PROPRIETARY_MEDICINE / FOOD_OR_NUTRACEUTICAL / COSMETIC_OR_PERSONAL_CARE (Evidence-Grounded)
REGULATORY PATH:              AYUSH_CLASSICAL_DRUG / AYUSH_STATE_LICENSING / AYURVEDA_AAHAR / COSMETIC_REGULATORY
DOCUMENT COMPLETENESS:        EVALUATED ACROSS 13 STATUTORY AREAS
CLAIMS REVIEW:                SCRUTINIZED AGAINST DRUGS & MAGIC REMEDIES ACT 1954 & FSSAI
TK:                           GROUNDED IN FIRST SCHEDULE TREATISES & SECTION 3(p) EXCLUSIONS
ABS:                          GOVERNED BY SECTION 6 OF BIOLOGICAL DIVERSITY ACT, 2002
IP:                           TRADEMARK, DESIGN, COPYRIGHT, TRADE SECRET, CONDITIONAL PATENT
DATASET SHA-256:              827f8a209ff7cbc86c00931fbb97d6eeaa861cdf360fa8770dafcf0fab05700d (PASS)
BACKEND TESTS:                176 / 176 PASSED (100% PASS)
FRONTEND TESTS:               29 / 29 PASSED (100% PASS)
PYTHON RAG TESTS:             77 PASSED (0 FAILURES)
FRONTEND BUILD:               PASS (Vite production bundle deployed)
SYSTEM STATUS:                READY FOR FURTHER REGULATORY REVIEW
============================================================
```
